AIMT News and Press, Aimmune Therapeutics Inc.

— Majority of Patients Experienced Low Rates of Adverse Events, Which Declined in Frequency and Severity with Continued Treatment — — Systemic Allergic Reactions and Epinephrine Use Were Low and Decreased Over Time — Aimmune Therapeutics, ...

-- Peanut Allergy is One of the Most Common Food Allergies in Europe -- -- Up to 1.6% of European Children Live with Potentially Life-Threatening Peanut Allergy -- Aimmune Therapeutics, Inc., a Nestlé Health Science Company, today announced that the European Com...

Merger activity moderated again last week with three new deals announced. The acquisition of Acorn International by First Ostia Port. The merger of DouYu International Holdings Limited and HUYA Inc. For further details see: Merger Arbitrage Mondays - 2 Potential Deals Co...

Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m. on Seeking Alpha, iTunes, Stitcher and Spotify. Anticipation builds for iPhone 12Wedbush is calling today's Apple (AAPL) iPhone event a "once in a decade" potential launch, and the stock is responding ac...

Société des Produits Nestlé S.A. ((SPN)), a Nestle (NSRGY) subsidiary announces the results of the tender offer, to purchase all of the outstanding shares of Aimmune Therapeutics' (AIMT) common stock for $34.50/share. The offer expired on October 9. Equinity Trust Company,...

Virtusa moves ahead as investors get on board with the acquisition by Barings Private Equity Asia. The possibility still remains for a higher offer for Virtusa. Merger arbitrage cash spreads narrow as the broader market powers ahead. For further details see: Merger Arbit...

AIMT's stock fell precipitously amid the COVID-19 pandemic, despite receiving FDA approval for its Palforzia treatment (the first FDA approved treatment for peanut allergies). Nestle has commenced a tender offer to purchase shares of AIMT at $34.50 per share and it is trying to take a...

Aimmune to be acquired by Nestle for $2.6 billion. Mallinckrodt receives a CRL for Terlipressin. Cassava reports positive final data for Alzheimer’s treatment. For further details see: Nestle Acquiring Aimmune, And Other News: The Good, Bad And Ugly Of Biopharma ...

NEW YORK , Sept. 17, 2020 /PRNewswire/ -- Halper Sadeh LLP, a global investor rights law firm, is investigating: Varian Medical Systems, Inc. (NYSE: VAR)   concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relat...

This weekly column explains the reasons behind the movement in a selection of the largest U.S. cash merger arbitrage spreads from the past week as calculated by Merger Arbitrage Limited. We analyze the attractiveness and profitability of each spread going forward and indicate the trading pos...